Rebecca Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rebecca Smith has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Ivan Ahel
Sir William Dunn School of Pathology, University of Oxford, Oxford, UK
11 shared publications - Sébastien Huet
University of Rennes
10 shared publications - Gyula Timinszky
Laboratory of DNA Damage and Nuclear Dynamics, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Hungary
8 shared publications - Catherine Chapuis
IGDR (Institut de Génétique et Développement de Rennes), UMR 6290 & BIOSIT (Biologie, Santé, Innovation Technologique), UAR 3480, Université Rennes, CNRS, Rennes, France
7 shared publications Dragana Ahel
Sir William Dunn School of Pathology, University of Oxford, Oxford, UK
5 shared publications- Kang Zhu
Health Science Center, East China Normal University , Shanghai 200241
5 shared publications
Latest Publications
- Open Access
Nucleolar endonuclease MBLAC2 orchestrates co-transcriptional ribosomal RNA processing and global transcriptional output
The metallo-β-lactamase (MBL)-domain superfamily includes multiple nucleases that process distinct transcript classes. We show that human MBLAC2 acts as a ribosomal (r)RNA quality control factor, being nucleolar specific, chromatin-associated and required for co-transcriptional pre-rRNA processing. Notably MBLAC2 is functionally distinct from other MBL containing proteins, being required for maintenance of nucleolar architecture, cell cycle progression and proliferative fitness. Selective MBLAC2 depletion causes accumulation of pre-rRNA intermediates that lead to perturbed RNA polymerase (Pol) I-associated RNA homeostasis and nucleolar stress signalling. Nascent RNA profiling with long-read nanopore sequencing reveals extended and aberrant pre-rRNA species, consistent with defective processing and transcript release. Remarkably disruption of rRNA processing reduces global Pol II transcriptional output, even though the Pol II nuclear distribution remains unchanged across genomic compartments. Altogether, we define MBLAC2 as the nucleolar branch of an MBL-domain RNA surveillance network that couples rRNA quality control with transcriptional homeostasis.
Open AccessNucleolar endonuclease MBLAC2 orchestrates co-transcriptional ribosomal RNA processing and global transcriptional output
The metallo-β-lactamase (MBL)-domain superfamily includes multiple nucleases that process distinct transcript classes. We show that human MBLAC2 acts as a ribosomal (r)RNA quality control factor, being nucleolar specific, chromatin-associated and required for co-transcriptional pre-rRNA processing. Notably MBLAC2 is functionally distinct from other MBL containing proteins, being required for maintenance of nucleolar architecture, cell cycle progression and proliferative fitness. Selective MBLAC2 depletion causes accumulation of pre-rRNA intermediates that lead to perturbed RNA polymerase (Pol) I-associated RNA homeostasis and nucleolar stress signalling. Nascent RNA profiling with long-read nanopore sequencing reveals extended and aberrant pre-rRNA species, consistent with defective processing and transcript release. Remarkably disruption of rRNA processing reduces global Pol II transcriptional output, even though the Pol II nuclear distribution remains unchanged across genomic compartments. Altogether, we define MBLAC2 as the nucleolar branch of an MBL-domain RNA surveillance network that couples rRNA quality control with transcriptional homeostasis.
- 18 December 2025
- Published by EMBL-EBI
Specificity and recognition of the ADPr-Ub modification in the DNA damage response
- 18 December 2025
- Published by EMBL-EBI
Specificity and recognition of the ADPr-Ub modification in the DNA damage response
- Open Access
- 1 December 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (1) , 261-277
Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation
ADP-ribosylation is an important protein post-translational modification catalysed by a family of PARP enzymes in humans and is involved in DNA damage and immunity among other processes. While poly-ADP-ribosylation has been established as a protein degradation signal in several cases, the role of mono-ADP-ribosylation in protein turnover has remained elusive and mostly relies on overexpression systems. Here, we describe a way to visualise high levels of endogenous ADP-ribosylation by inhibiting the ubiquitin pathway. By blocking ubiquitylation/proteasome, we found that ADP-ribosylation by at least three different PARPs (PARP7, PARP1 and TNKS) can be greatly induced. We discovered that specific activation of the aryl hydrocarbon receptor (AHR) pathway in combination with the ubiquitin pathway inhibition promotes quantitative ADP-ribosylation of PARP7 targets, including the mono-ADP-ribosyltransferase PARP7 itself and AHR. We found that DTX2 is the E3 ligase responsible for degrading ADP-ribosylated PARP7, AHR and other PARP7 substrates. This PARP7-DTX2 crosstalk establishes a mechanism to rapidly shut down AHR-mediated transcription by decreasing its protein levels. Taken together, our findings uncover a paradigm where mono-ADP-ribosylation acts as a degradation mark.
- 1 December 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (1) , 261-277
Open AccessUbiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation
ADP-ribosylation is an important protein post-translational modification catalysed by a family of PARP enzymes in humans and is involved in DNA damage and immunity among other processes. While poly-ADP-ribosylation has been established as a protein degradation signal in several cases, the role of mono-ADP-ribosylation in protein turnover has remained elusive and mostly relies on overexpression systems. Here, we describe a way to visualise high levels of endogenous ADP-ribosylation by inhibiting the ubiquitin pathway. By blocking ubiquitylation/proteasome, we found that ADP-ribosylation by at least three different PARPs (PARP7, PARP1 and TNKS) can be greatly induced. We discovered that specific activation of the aryl hydrocarbon receptor (AHR) pathway in combination with the ubiquitin pathway inhibition promotes quantitative ADP-ribosylation of PARP7 targets, including the mono-ADP-ribosyltransferase PARP7 itself and AHR. We found that DTX2 is the E3 ligase responsible for degrading ADP-ribosylated PARP7, AHR and other PARP7 substrates. This PARP7-DTX2 crosstalk establishes a mechanism to rapidly shut down AHR-mediated transcription by decreasing its protein levels. Taken together, our findings uncover a paradigm where mono-ADP-ribosylation acts as a degradation mark.
- Open Access
- 17 November 2025
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 32 (12) , 2526-2541
Filament formation and NAD processing by noncanonical human FAM118 sirtuins
Sirtuins are an ancient family of enzymes with diverse nicotinamide adenine dinucleotide (NAD)-dependent activities. Here we identify family with sequence similarity 118 member B (FAM118B) and FAM118A—two understudied vertebrate proteins—as vertebrate-specific sirtuins with similarities to bacterial antiphage sirtuins. We show that human FAM118B forms head-to-tail filaments both in vitro and in living human cells, a feature that appears to be conserved in both FAM118B and its paralog FAM118A across vertebrates. While human FAM118B and FAM118A have individually very weak NAD-processing activity in vitro, their interaction leads to markedly increased activity, suggesting a tightly regulated system. The overexpression of wild-type human FAM118B and FAM118A leads to strongly decreased NAD levels in human cells, an effect that is abolished in catalytically dead or filament-deficient mutants. Our study highlights filament formation and NAD processing as conserved mechanisms among immunity-associated sirtuins across evolution.
- 17 November 2025
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 32 (12) , 2526-2541
Open AccessFilament formation and NAD processing by noncanonical human FAM118 sirtuins
Sirtuins are an ancient family of enzymes with diverse nicotinamide adenine dinucleotide (NAD)-dependent activities. Here we identify family with sequence similarity 118 member B (FAM118B) and FAM118A—two understudied vertebrate proteins—as vertebrate-specific sirtuins with similarities to bacterial antiphage sirtuins. We show that human FAM118B forms head-to-tail filaments both in vitro and in living human cells, a feature that appears to be conserved in both FAM118B and its paralog FAM118A across vertebrates. While human FAM118B and FAM118A have individually very weak NAD-processing activity in vitro, their interaction leads to markedly increased activity, suggesting a tightly regulated system. The overexpression of wild-type human FAM118B and FAM118A leads to strongly decreased NAD levels in human cells, an effect that is abolished in catalytically dead or filament-deficient mutants. Our study highlights filament formation and NAD processing as conserved mechanisms among immunity-associated sirtuins across evolution.
- Open Access
- 9 October 2025
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 69 (04) , 267-279
Interplay between ubiquitination and ADP-ribosylation and the case of dual modification ADPr-Ub
Ubiquitination is a fundamental post-translational modification essential for nearly all cellular activities. Traditionally, ubiquitination has been understood as a protein modification, where ubiquitin (Ub) molecules are covalently attached to the lysine residues of substrate proteins, thereby modulating their function, localization, or degradation. However, recent discoveries have expanded the scope of ubiquitination beyond protein substrates. One of the examples is ubiquitination of ADP-ribose moieties on proteins or nucleic acids that leads to the formation of a dual-hybrid modification ADP-ribose-Ub (ADPr-Ub). This novel form of ubiquitination is catalyzed by Deltex ubiquitin ligases that act in concert with PARPs (Poly (ADP-ribose) polymerases), enzymes modifying their substrates by ADPr modification. This review summarizes our current knowledge of mechanisms and potential functional implications of ADPr-Ub. We also cover other examples of the interplay between ADP-ribosylation (ADPr) and ubiquitination beyond Deltex enzymes and ADPr-Ub.
- 9 October 2025
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 69 (04) , 267-279
Open AccessInterplay between ubiquitination and ADP-ribosylation and the case of dual modification ADPr-Ub
Ubiquitination is a fundamental post-translational modification essential for nearly all cellular activities. Traditionally, ubiquitination has been understood as a protein modification, where ubiquitin (Ub) molecules are covalently attached to the lysine residues of substrate proteins, thereby modulating their function, localization, or degradation. However, recent discoveries have expanded the scope of ubiquitination beyond protein substrates. One of the examples is ubiquitination of ADP-ribose moieties on proteins or nucleic acids that leads to the formation of a dual-hybrid modification ADP-ribose-Ub (ADPr-Ub). This novel form of ubiquitination is catalyzed by Deltex ubiquitin ligases that act in concert with PARPs (Poly (ADP-ribose) polymerases), enzymes modifying their substrates by ADPr modification. This review summarizes our current knowledge of mechanisms and potential functional implications of ADPr-Ub. We also cover other examples of the interplay between ADP-ribosylation (ADPr) and ubiquitination beyond Deltex enzymes and ADPr-Ub.
- 20 September 2025
- Published by EMBL-EBI
Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation
BioStudies – one package for all the data supporting a study
- 20 September 2025
- Published by EMBL-EBI
Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation
BioStudies – one package for all the data supporting a study
- Open Access
- 9 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Identification of RNF114 as ADPr-Ub reader through non-hydrolysable ubiquitinated ADP-ribose
Crosstalk between the post-translational modification processes of ubiquitination and ADP-ribosylation occurs in DNA-damage- and immune-responses, in addition the physical linkage of ADP-ribose and ubiquitin is found during bacterial infection. Here, we study the ubiquitination of ADP-ribose mediated by human Deltex E3 ligases and the subsequent fate of the formed hybrid post-translational modification. We prepare a non-hydrolysable ADPr-Ub probe that we employ in a proteomics approach and identify RNF114 as an interacting protein. Using biophysical and biochemical experiments, we validate that RNF114 preferentially interacts with ubiquitinated ADP-ribose over non-modified ubiquitin. Subsequently, RNF114 can elongate the ubiquitinated ADP-ribose with a K11-linked ubiquitin chain. Using domain deletion analysis, we pinpoint the tandem zinc fingers and ubiquitin interacting motif (ZnF2 + ZnF3+UIM) domains of RNF114 to be crucial for recognising ubiquitinated ADP-ribose. Moreover, these domains are essential for the recruitment of RNF114 to the sites of laser-induced DNA damage.
- 9 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Open AccessIdentification of RNF114 as ADPr-Ub reader through non-hydrolysable ubiquitinated ADP-ribose
Crosstalk between the post-translational modification processes of ubiquitination and ADP-ribosylation occurs in DNA-damage- and immune-responses, in addition the physical linkage of ADP-ribose and ubiquitin is found during bacterial infection. Here, we study the ubiquitination of ADP-ribose mediated by human Deltex E3 ligases and the subsequent fate of the formed hybrid post-translational modification. We prepare a non-hydrolysable ADPr-Ub probe that we employ in a proteomics approach and identify RNF114 as an interacting protein. Using biophysical and biochemical experiments, we validate that RNF114 preferentially interacts with ubiquitinated ADP-ribose over non-modified ubiquitin. Subsequently, RNF114 can elongate the ubiquitinated ADP-ribose with a K11-linked ubiquitin chain. Using domain deletion analysis, we pinpoint the tandem zinc fingers and ubiquitin interacting motif (ZnF2 + ZnF3+UIM) domains of RNF114 to be crucial for recognising ubiquitinated ADP-ribose. Moreover, these domains are essential for the recruitment of RNF114 to the sites of laser-induced DNA damage.
- Open Access
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents
- Open Access
- 25 September 2024
- Published by Springer Nature in The EMBO Journal
- Vol. 43 (21) , 5327
Author Correction: PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation
- 25 September 2024
- Published by Springer Nature in The EMBO Journal
- Vol. 43 (21) , 5327
Open AccessAuthor Correction: PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation
- Open Access
- 4 June 2024
- Published by Springer Nature in The EMBO Journal
- Vol. 43 (14) , 2929-2953
PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation
PARP-catalysed ADP-ribosylation (ADPr) is important in regulating various cellular pathways. Until recently, PARP-dependent mono-ADP-ribosylation has been poorly understood due to the lack of sensitive detection methods. Here, we utilised an improved antibody to detect mono-ADP-ribosylation. We visualised endogenous interferon (IFN)-induced ADP-ribosylation and show that PARP14 is a major enzyme responsible for this modification. Fittingly, this signalling is reversed by the macrodomain from SARS-CoV-2 (Mac1), providing a possible mechanism by which Mac1 counteracts the activity of antiviral PARPs. Our data also elucidate a major role of PARP9 and its binding partner, the E3 ubiquitin ligase DTX3L, in regulating PARP14 activity through protein-protein interactions and by the hydrolytic activity of PARP9 macrodomain 1. Finally, we also present the first visualisation of ADPr-dependent ubiquitylation in the IFN response. These approaches should further advance our understanding of IFN-induced ADPr and ubiquitin signalling processes and could shed light on how different pathogens avoid such defence pathways.
- 4 June 2024
- Published by Springer Nature in The EMBO Journal
- Vol. 43 (14) , 2929-2953
Open AccessPARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation
PARP-catalysed ADP-ribosylation (ADPr) is important in regulating various cellular pathways. Until recently, PARP-dependent mono-ADP-ribosylation has been poorly understood due to the lack of sensitive detection methods. Here, we utilised an improved antibody to detect mono-ADP-ribosylation. We visualised endogenous interferon (IFN)-induced ADP-ribosylation and show that PARP14 is a major enzyme responsible for this modification. Fittingly, this signalling is reversed by the macrodomain from SARS-CoV-2 (Mac1), providing a possible mechanism by which Mac1 counteracts the activity of antiviral PARPs. Our data also elucidate a major role of PARP9 and its binding partner, the E3 ubiquitin ligase DTX3L, in regulating PARP14 activity through protein-protein interactions and by the hydrolytic activity of PARP9 macrodomain 1. Finally, we also present the first visualisation of ADPr-dependent ubiquitylation in the IFN response. These approaches should further advance our understanding of IFN-induced ADPr and ubiquitin signalling processes and could shed light on how different pathogens avoid such defence pathways.